Clinical Trial Update: Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating ketamine as a rapidly-acting antidepressant in depressed emergency department patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: NYU Langone Health | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-09-14